Abbott Laboratories (ABT) Interest & Investment Income (2009 - 2026)

Abbott Laboratories has disclosed Interest & Investment Income across 18 years of filings, most recently posting $106.0 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $106.0 million, up 29.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $332.0 million (down 4.05% YoY), and the FY2025 annual result was $308.0 million, down 10.47% from the prior year.
• Interest & Investment Income came in at $106.0 million for Q1 2026 at Abbott Laboratories, up from $78.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $106.0 million in Q1 2026 to a low of $14.0 million in Q1 2022.
• The 5-year median for Interest & Investment Income is $82.0 million (2024), against an average of $78.0 million.
• Across the five-year window, Interest & Investment Income jumped 700.0% in 2022 and dropped 20.79% in 2024, its largest moves.
• Abbott Laboratories' Interest & Investment Income stood at $88.0 million in 2022, then rose by 1.14% to $89.0 million in 2023, then advanced by 2.25% to $91.0 million in 2024, then fell by 14.29% to $78.0 million in 2025, then jumped by 35.9% to $106.0 million in 2026.
• The last three Interest & Investment Income figures came in at $106.0 million (Q1 2026), $78.0 million (Q4 2025), and $77.0 million (Q3 2025), per Business Quant data.